|
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not
intended to be used as a source of information on on healthcare or medicines.
The web pages are not kept up to date and are for demonstration purposes only.
For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines
or the package leaflet of your medicine. For up-to-date information on other
healthcare topics, please consult the relevant reliable sources or an healthcare
expert, such as a physician etc.
|
BACK TO LIST |
|
|
|
|||||||||||||||||||
| Condition | Onset Date / Period | Status |
|---|---|---|
| Essential hypertension | 06-Oct-2024 | active |
| Metabolic syndrome X | 06-Oct-2024 | active |
| Hypertriglyceridemia | 06-Oct-2024 | active |
| Type 2 diabetes mellitus | 03-Oct-2021 | active |
| Anemia | 27-Sep-2015 | active |
| Recurrent urinary tract infection | 22-Mar-2010 | active |
| Miscarriage in first trimester | 07-Apr-2024 - 26-Apr-2024 | inactive |
| Blighted ovum | 07-Apr-2024 - 26-Apr-2024 | inactive |
| Concussion with no loss of consciousness | 31-Jul-2021 - 11-Sep-2021 | inactive |
| Concussion injury of brain | 31-Jul-2021 - 11-Sep-2021 | inactive |
| Acute bronchitis | 28-Aug-2019 - 06-Sep-2019 | inactive |
| Acute viral pharyngitis | 11-Nov-2018 - 23-Nov-2018 | inactive |
| Acute bronchitis | 18-Oct-2015 - 26-Oct-2015 | inactive |
| Medication | Since | Form | Dosage | Reason |
|---|---|---|---|---|
| Lisinopril 10 mg oral tablet | 2024-11-05 | - | 1 tablet (10 mg) by mouth once daily | Essential hypertension (disorder) |
| Amlodipine (as amlodipine besylate) 2.5 mg oral tablet | 2024-10-06 | - | 1 tablet (2.5 mg) by mouth once daily | Essential hypertension (disorder) |
| Vaccine | Date |
|---|---|
| Clostridium tetani toxoid antigen adsorbed only vaccine product | 06-Oct-2024 |
| Influenza virus antigen only vaccine product | 06-Oct-2024 |
| SARS-CoV-2 mRNA vaccine | 06-Jun-2021 |
| Hepatitis B virus antigen only vaccine product | 11-Oct-2015 |
| Neisseria meningitidis antigen-containing vaccine product | 27-Sep-2015 |
| Procedure | Date | Reason |
|---|---|---|
| Epidural anesthesia | 29-May-2022 | Normal pregnancy (finding) |
| Medical induction of labor | 25-Oct-2020 | Normal pregnancy (finding) |
| No known allergies or intolerances |
| Active Planned Care / Goals | Start Date | Reason |
|---|---|---|
| Lifestyle education regarding hypertension | 06-Oct-2024 | Essential hypertension (disorder) |
|
||
| Diabetes self management plan | 27-Sep-2015 | Prediabetes (finding) |
|
| Vital Signs | 2025-03-05 | 2025-01-04 |
|---|---|---|
| Blood pressure panel with all children optional | 89 mm[Hg] | 90 mm[Hg] |
| Recent Lab Observations | 06-OCT-2024 | Reference Range | Unit |
|---|---|---|---|
| Hemoglobin A1c/Hemoglobin.total in Blood | 7.1 H | 4.8 - 5.6 | % |
| Glucose [Mass/volume] in Blood | 110.8 H | 70 - 100 | mg/dL |
| Urea nitrogen [Mass/volume] in Blood | 15.3 | 7 - 20 | mg/dL |
| Creatinine [Mass/volume] in Blood | 1.0 | 0.5 - 1.2 | mg/dL |
| Calcium [Mass/volume] in Blood | 9.9 | 8.5 - 10.5 | mg/dL |
| Sodium [Moles/volume] in Blood | 137.2 | 135 - 145 | mmol/L |
| Potassium [Moles/volume] in Blood | 4.7 | 3.5 - 5.1 | mmol/L |
| Chloride [Moles/volume] in Blood | 104.3 | 98 - 107 | mmol/L |
| Carbon dioxide, total [Moles/volume] in Blood | 23.9 | 22 - 29 | mmol/L |
| Cholesterol [Mass/volume] in Serum or Plasma | 220.3 H | 125 - 200 | mg/dL |
| Triglyceride [Mass/volume] in Serum or Plasma | 168.0 H | 0 - 149 | mg/dL |
| Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay | 137.3 H | 0 - 100 | mg/dL |
| Cholesterol in HDL [Mass/volume] in Serum or Plasma | 49.4 | 40 - 60 | mg/dL |
| Microalbumin/Creatinine [Mass Ratio] in Urine | 16.9 | 0 - 30 | mg/g |
| Device | Date (since) |
|---|---|
| Blood glucose meter (physical object) | 27-Sep-2015 |